{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:07:42Z","timestamp":1785863262298,"version":"3.56.0"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Governo Italiano","award":["Italian Ministry of Health, Ricerca Corrente IRCCS Research program n.4 Tuberculosis and grant Ricerca Finalizzata COVID-2020-12371675"],"award-info":[{"award-number":["Italian Ministry of Health, Ricerca Corrente IRCCS Research program n.4 Tuberculosis and grant Ricerca Finalizzata COVID-2020-12371675"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Pulmonary thromboembolism (PTE) has been associated with tuberculosis (TB), but the true incidence is unknown. The aim of our study was to retrospectively evaluate the PTE prevalence in TB patients hospitalized at the National Institute for Infectious Diseases L. Spallanzani during the January 2016\u2013December 2021 period. Retrospective data collection and evaluation were conducted. Among 1801 TB patients, 29 (1.61%) exhibited PTE. Twenty (69%) had comorbidities; eleven (37.9%) had predisposing factors for PTE. Nineteen (65.5%) had extensive TB disease. The commonest respiratory symptoms were cough (37.9%), dyspnea (31%), chest pain (10.3%), and hemoptysis (6.9%). Twenty-five (86.2%) had elevated serum D-dimer levels. An increased prevalence of PTE from 0.6% in the pre-COVID-19 pandemic period to 4.6% in the pandemic period was found. Acute respiratory failure and extensive TB disease increased significantly in the pandemic period. The increase in PTE could be explained by the increased severity of TB in patients in the pandemic period and by increased clinical suspicion and, consequently, increased requests for D-dimer testing, including in patients with non-COVID-19 pneumonia. Patients with extensive pulmonary disease are at high risk of developing PTE. Clinicians should be aware of this potentially life-threatening complication of TB, and patients should receive a thromboembolism risk assessment.<\/jats:p>","DOI":"10.3390\/antibiotics11030398","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T22:09:58Z","timestamp":1647468598000},"page":"398","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-9705","authenticated-orcid":false,"given":"Virginia","family":"Di Bari","sequence":"first","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Gualano","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Musso","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Libertone","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5369-0437","authenticated-orcid":false,"given":"Carla","family":"Nisii","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Ianniello","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mosti","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelisa","family":"Mastrobattista","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-7313","authenticated-orcid":false,"given":"Carlotta","family":"Cerva","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazario","family":"Bevilacqua","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Iacomi","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Mondi","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Topino","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-4376","authenticated-orcid":false,"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-5896","authenticated-orcid":false,"given":"Enrico","family":"Girardi","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8184-6291","authenticated-orcid":false,"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[{"name":"National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the TB-INMI Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022, January 30). Global Tuberculosis Report 2019. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/329368."},{"key":"ref_2","unstructured":"European Centre for Disease Prevention and Control (2022, January 28). Annual Epidemiological Report for 2019. Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER-TB-2019.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiographics.21.4.g01jl06839","article-title":"Thoracic sequelae and complications of tuberculosis","volume":"21","author":"Kim","year":"2001","journal-title":"Radiographics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.mcna.2018.12.013","article-title":"Pulmonary Embolism","volume":"103","author":"Essien","year":"2019","journal-title":"Med. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/rth2.12065","article-title":"Acute infection as a trigger for incident venous thromboembolism: Results from a population-based case-crossover study","volume":"2","author":"Grimnes","year":"2017","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10096-018-3185-y","article-title":"Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review","volume":"37","author":"Ceccarelli","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1538-7836.2012.04732.x","article-title":"Pneumonia and risk of venous thrombosis: Results from the MEGA study","volume":"10","author":"Ribeiro","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.amjmed.2017.09.015","article-title":"Is Infection an Independent Risk Factor for Venous Thromboembolism? A Population-Based, Case-Control Study","volume":"131","author":"Cohoon","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0035-1556729","article-title":"Chronic Infection and Venous Thromboembolic Disease","volume":"41","author":"Epaulard","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cid\/cit780","article-title":"Active tuberculosis and venous thromboembolism: Association according to international classification of diseases, ninth revision hospital discharge diagnosis codes","volume":"58","author":"Dentan","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","first-page":"215","article-title":"Venous thrombotic events in patients admitted to a tuberculosis centre","volume":"110","author":"Bierman","year":"2017","journal-title":"QJM"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2014.10.006","article-title":"Pulmonary tuberculosis induces a systemic hypercoagulable state","volume":"70","author":"Kager","year":"2015","journal-title":"J. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3947\/ic.2019.51.2.142","article-title":"Thromboembolism in Mycobacterium tuberculosis Infection: Analysis and Literature Review","volume":"51","author":"Ha","year":"2019","journal-title":"Infect. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11239-020-02211-7","article-title":"Global epidemiology of venous thromboembolism in people with active tuberculosis: A systematic review and meta-analysis","volume":"51","author":"Danwang","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_17","unstructured":"WHO (2020). WHO Consolidated Guidelines on Tuberculosis: Module 4: Treatment-Drug-Resistant Tuberculosis Treatment [Internet], World Health Organization."},{"key":"ref_18","first-page":"18","article-title":"Epidemiology of pulmonary embolism in Apulia from analysis of current data","volume":"73","author":"Moretti","year":"2010","journal-title":"Monaldi Arch. Chest Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.ejim.2013.01.007","article-title":"Incidence and diagnosis of pulmonary embolism in Northern Italy: A population-based study","volume":"24","author":"Pomero","year":"2013","journal-title":"Eur. J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjmed.2019.03.021","article-title":"Reasons for Differences in the Incidence of Venous Thromboembolism in Black Versus White Americans","volume":"132","author":"Folsom","year":"2019","journal-title":"Am. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Andersson, T., and S\u00f6derberg, S. (2017). Incidence of acute pulmonary embolism, related comorbidities and survival; analysis of a Swedish national cohort. BMC Cardiovasc. Disord., 17.","DOI":"10.1186\/s12872-017-0587-1"},{"key":"ref_22","unstructured":"Uflacker, R. (1997). Atlas of Vascular Anatomy: An Angiographic Approach, Lippencott Williams & Wilkins. [1st ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5320\/wjr.v9.i3.30","article-title":"Diagnosis and treatment of subsegmental pulmonary embolism","volume":"9","author":"Newnham","year":"2019","journal-title":"World J. Respirol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00259-019-04450-0","article-title":"EANM guideline for ventilation\/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond","volume":"46","author":"Bajc","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"631696","DOI":"10.3389\/fimmu.2021.631696","article-title":"Platelet Activation and the Immune Response to Tuberculosis","volume":"12","author":"Kirwan","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_26","first-page":"927","article-title":"Hemostatic changes in active pulmonary tuberculosis","volume":"6","author":"Turken","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.4049\/jimmunol.144.10.3804","article-title":"IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6","volume":"144","author":"Gauldie","year":"1990","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/TA.0000000000000233","article-title":"Pulmonary embolism without deep venous thrombosis: De novo or missed deep venous thrombosis?","volume":"76","author":"Zander","year":"2014","journal-title":"J. Trauma Acute Care Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"983991","DOI":"10.1164\/rccm.200908-1204OC","article-title":"Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism","volume":"181","author":"Jimenez","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s11239-019-01967-x","article-title":"Severe pulmonary tuberculosis complicated with insidious pulmonary thromboembolism: A case report and literature review","volume":"49","author":"Huang","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1046\/j.1365-2141.1996.d01-1722.x","article-title":"Acute-phase response and the hypercoagulable state in pulmonary tuberculosis","volume":"93","author":"Robson","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(89)90603-X","article-title":"Venous thrombosis and rifampicin","volume":"2","author":"White","year":"1989","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.18410\/jebmh\/2018\/644","article-title":"Rifampicin containg ATT regimens as emerging cause of thromboembolic complications","volume":"5","author":"Saluja","year":"2018","journal-title":"J. Evid. Based Med. Healthc."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Di Gennaro, F., Gualano, G., Timelli, L., Vittozzi, P., Di Bari, V., Libertone, R., Cerva, C., Pinnarelli, L., Nisii, C., and Ianniello, S. (2021). Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. Antibiotics, 10.","DOI":"10.3390\/antibiotics10030272"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/qjmed\/hcm113","article-title":"The value of clinical features in the diagnosis of acute pulmonary embolism: Systematic review and meta-analysis","volume":"100","author":"West","year":"2007","journal-title":"QJM"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.acvd.2019.09.009","article-title":"Clinical patterns and significance of non-compliance with guideline-recommended treatment of acute pulmonary embolism","volume":"113","author":"Cart","year":"2020","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M20-2566","article-title":"Pulmonary arterial thrombosis in COVID-19 with fatal outcome: Results from a prospective, singlecenter, clinicopathologic case series","volume":"173","author":"Lax","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: Prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Cushman","year":"2018","journal-title":"Blood Adv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: Findings from the IMPROVE investigators","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/QCO.0000000000000090","article-title":"Complications of tuberculosis","volume":"27","author":"Maunank","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0972-5229.68215","article-title":"Interpretation of arterial blood gas","volume":"14","author":"Sood","year":"2010","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_43","unstructured":"World Health Organitation (WHO) (2017). Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care, WHO. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255052\/9789241550000-eng.pdf."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/3\/398\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:43Z","timestamp":1760135863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/3\/398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["antibiotics11030398"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11030398","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}